TELA Bio, Inc.: cashflow_financing
| Value | {"amount": 40852000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | TELA Bio, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:52:15.364627+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b4bfe7d0-9b36-4a5b-adf1-33c04c6e04a4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-23-004468Retrieved: 2026-08-19T15:52:15.364627+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001561921/cashflow-financing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b4bfe7d0-9b36-4a5b-adf1-33c04c6e04a4
History
- no predecessors — first report